Breast Cancer Update Home - Oncology Leader Commentary

Home: Oncology Leader Commentary: Craig Hederson, MD

Click on the topic below for comments by Dr Craig Henderson to comment on. You will also find links to related articles and clinical trials.

Historical perspective on adjuvant endocrine therapy
More recent trials of adjuvant ovarian ablation
Intergroup trial of adjuvant endocrine therapy
Is tamoxifen more effective in a low estrogen environment
Zoladex plus tamoxifen as adjuvant therapy
Choosing a method of ovarian ablation
Age and menopausal status
Adjuvant chemotherapy and the ovaries
Emotional issues in decision-making
Combining tamoxifen and an aromatase inhibitor in postmenopausal women
Taxanes as adjuvant therapy
Nodal status and choice of adjuvant systemic therapy
Timing of radiation therapy with AC-Taxol
Dose of adjuvant chemotherapy
Liposomal delivery of cytotoxics

Home

Patrick I. Borgen, MD

Aman Buzdar, MD

Nancy E. Davidson, MD

J. Michael Dixon, MD

Armando Giuliano, MD

I. Craig Henderson, MD

David Krag, MD

Gershon Locker, MD

Charles Loprinzi, MD

Richard Margolese, MD

Monica Morrow, MD

C Kent Osborne, MD

Sir Richard Peto, FRS

Kathy I. Pritchard, MD

John F. Robertson, MD,FRCS

Andrew D. Seidman, MD

George W. Sledge, MD

Home · Contact us

Terms of use and general disclaimer